Literature DB >> 6442626

Antibiotic administration and oral bacterial therapy in infants.

G Benoni, V Marcer, L Cuzzolin, F Raimo.   

Abstract

Feces samples of 35 children, aged between 3 and 24 months (mean age 12 months), were analyzed. Sixteen children who had no therapy were considered as "control samples"; an antibiotic therapy was administered to 8 subjects for at least 5 days for extraintestinal pathology (ampicillin, orally, at a dose of 100 mg/kg/die in three doses). Finally, the same antibiotic therapy with the addition, from the beginning over 5 days, of the oral preparation of Bacillus subtilis spores (4 X 10(9) die) was administered to 11 patients. During antibiotic therapy, the number of stools per day increased, but not for those patients taking B. subtilis spores. Regarding the bacterial flora, the subjects treated with antibiotic therapy alone showed a significant decrease of all aerobic species, except for fungi, anaerobic total count and aerobic cocci. After oral bacteriotherapy together with ampicillin, we observed an increase of saccharolytic flora, aerobic and anaerobic, while proteolytic flora did not show any changes.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6442626

Source DB:  PubMed          Journal:  Chemioterapia        ISSN: 0392-906X


  4 in total

1.  Bifidobacterium adolescentis is intrinsically resistant to antitubercular drugs.

Authors:  Dhanashree Lokesh; Raman Parkesh; Rajagopal Kammara
Journal:  Sci Rep       Date:  2018-08-09       Impact factor: 4.379

2.  Kinetics of Intestinal Presence of Spores Following Oral Administration of Bacillus clausii Formulations: Three Single-Centre, Crossover, Randomised, Open-Label Studies.

Authors:  Pierluigi Navarra; Stefano Milleri; Marcos Perez Iii; Maria Chiara Uboldi; Paolo Pellegrino; Beatrice Bois De Fer; Lorenzo Morelli
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2021-03-08       Impact factor: 2.441

Review 3.  Bacillus clausii for Gastrointestinal Disorders: A Narrative Literature Review.

Authors:  Carlos Patricio Acosta-Rodríguez-Bueno; Ana Teresa Abreu Y Abreu; Francisco Guarner; Mary Jean V Guno; Ender Pehlivanoğlu; Marcos Perez
Journal:  Adv Ther       Date:  2022-08-26       Impact factor: 4.070

4.  Comparative secretome analysis of four isogenic Bacillus clausii probiotic strains.

Authors:  Rosa Lippolis; Rosa Anna Siciliano; Maria Fiorella Mazzeo; Anna Abbrescia; Antonio Gnoni; Anna Maria Sardanelli; Sergio Papa
Journal:  Proteome Sci       Date:  2013-07-01       Impact factor: 2.480

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.